Back
RAPT Therapeutics Stock Predictions
Sell
11
RAPT
RAPT Therapeutics
Last Price:
4.01
Seasonality Move:
56.89%
7 Day Trial
ALL ACCESS PASS
$
7
RAPT Therapeutics Stock Forecast
-
Is RAPT Therapeutics Stock Undervalued?
The current RAPT Therapeutics [RAPT] share price is $4.04. The Score for RAPT is 11, which is 78% below its historic median score of 50, and infers higher risk than normal. - RAPT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will RAPT Therapeutics Stock Go Up Next Year?
Data Unavailable
RAPT Therapeutics Stock Rating
Data Unavailable
RAPT Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
rapt.com
52-Week Data
52-Week High:
27.35
52-Week Low:
3.98
Prediction Charts
Market Cap:
141.01M
Price in USD:
4.04
Volume:
542.35K
Beta:
0.53
Technical Analysis
SMA50:
7.75
SMA100:
14.20
SMA200:
15.53
52-Wk Change:
-80.81%
Stock Predictions
-
Is RAPT Therapeutics stock public?
Yes, RAPT Therapeutics is a publicly traded company. -
What is the RAPT Therapeutics stock quote today?
The RAPT Therapeutics stock price is 4.04 USD today. -
How to buy RAPT Therapeutics stock online?
You can buy RAPT Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-30 | 7.84 | 7.70 | 7.96 | 7.68 |
| May-1 | 7.72 | 8.18 | 8.53 | 7.71 |
| May-2 | 8.31 | 8.13 | 8.43 | 8.05 |
| May-3 | 8.28 | 8.33 | 8.58 | 8.15 |
| May-6 | 8.39 | 8.28 | 8.44 | 8.20 |
| May-7 | 8.27 | 8.08 | 8.30 | 8.03 |
| May-8 | 8.00 | 7.98 | 8.12 | 7.82 |
| May-9 | 5.25 | 4.65 | 6.05 | 4.39 |
| May-10 | 4.54 | 4.33 | 4.63 | 4.18 |
| May-13 | 4.33 | 4.40 | 4.48 | 4.31 |
| May-14 | 4.35 | 4.00 | 4.42 | 3.98 |
| May-15 | 4.10 | 4.25 | 4.29 | 4.05 |
| May-16 | 4.25 | 4.14 | 4.27 | 4.08 |
| May-17 | 4.17 | 4.04 | 4.23 | 4.03 |
RAPT Therapeutics Earnings
Data Unavailable
RAPT Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.04 per share, an increase this year of $0.59 per share, and an increase next year of $0.11 per share.
* RAPT Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.